Nobody dares stopping clinical research, not even COVID-19

Competing interests

S.D.C.: fees for medical education from Novartis and Pierre-Fabre; recipient of the IG20774 of Fondazione Associazione Italiana Ricerca contro il Cancro (AIRC). J.M.P.-G.: consultant/advisory board member for Roche, Lilly; travel, accommodation paid by Roche. A.L.-C.: leadership role for Eisai, Celgene, Lilly, Pfizer, Roche, Novartis, Roche, MSD; stock or other ownership in MEDSIR and Initia-Research;...